الحل الكامل للاستجابة لـ COVID-19
استجابة لوباء COVID-19 سريع التطور وموسم الأنفلونزا القادم ، تلتزم Seegene باستمرار تطوير ودعم الأدوات الفعالة لمكافحة هذا الوباء العالمي
Full Screening and Identification
for SARS-CoV-2 and Variants
Full screening for SARS-CoV-2 and Variants
Full screening for SARS-CoV-2 and variants
including the five notable mutations in S gene
Identification of SARS-CoV-2 Variants
Identification of major SARS-CoV-2 variants of
concern and highly conserved region in RdRP gene
Identification of SARS-CoV-2 Variants
Identification of major SARS-CoV-2
variants of concern
Identification of SARS-CoV-2 Variants
Accurate detection of SARS-CoV-2
Delta variants
Identification of SARS-CoV-2 Variants
Accurate detection of SARS-CoV-2
Delta & Lambda variants
Identification of SARS-CoV-2 Variants
Accurate detection of SARS-CoV-2
Lamda & Mu variants
Identification of SARS-CoV-2 Variants
Accurate detection of SARS-CoV-2
and Omicron-specific mutations
Move Forward to Defeat SARS-CoV-2 Variants
Seegene utilizes bioinformatics (SG-Insilico™) to monitor newly emerging SARS-CoV-2 sequence information on a regular basis and design optimized diagnostic assay.
Multiplex Real-time PCR assay portfolio
for COVID-19 and Variants
Analytes
Allplex™ 2019-nCoV Assay
- - N gene
- - RdRP gene
- - E gene
- - Exogenous internal control (IC)
Allplex™ SARS-CoV-2 Assay
- - N gene
- - RdRP/S gene
- - E gene
- - Exogenous internal control (IC)
Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
- - N gene
- - RdRP/S gene
- - Influenza A
- - Influenza B
- - RSV A/B
- - Endogenous internal control (IC)
- - Exogenous internal control (IC)
Allplex™ SARS-CoV-2 Master Assay
- - E gene
- - N gene
- - RdRP/S gene
- - HV 69/70 deletion, N501Y, E484K, Y144 deletion and P681H in S gene
- - Endogenous internal control (IC)
Allplex™ SARS-CoV-2 Variants I Assay
- - RdRP gene
- - E484K in S gene
- - N501Y in S gene
- - HV69/70 deletion in S gene
- - Endogenous internal control (IC)
Allplex™ SARS-CoV-2 Variants II Assay
- - L452R in S gene
- - W152C in S gene
- - K417N in S gene
- - K417T in S gene
- - Endogenous internal control (IC)
Novaplex™ SARS-CoV-2 Variants IV Assay (RUO)
- - L452R in S gene
- - P681R in S gene
- - K417N in S gene
- - Endogenous internal control (IC)
Novaplex™ SARS-CoV-2 Variants V Assay (RUO)
- - F490S in S gene
- - P681R in S gene
- - L452Q in S gene
- - L452R in S gene
- - Endogenous internal control (IC)
Novaplex™ SARS-CoV-2 Variants VI Assay (RUO)
- - L452Q in S gene
- - F490S in S gene
- - R346K in S gene
- - D950N in S gene
- - Endogenous internal control (IC)
Novaplex™ SARS-CoV-2 Variants VII Assay (RUO)
- - E484A in S gene
- - HV69/70 deletion in S gene
- - N501Y in S gene
- - RdRP gene
- - Endogenous internal control (IC)
Allplex™ SARS-CoV-2 fast PCR Assay
- - E gene
- - N gene
- - RdRP gene
- - Endogenous internal control (IC)
Summary of Seegene's COVID-19 assay
Expanded selectivity of syndromic test
Allplex™ SARS-CoV-2 Master Assay can be used alone or expanded to syndromic test with respiratory essential panel for common respiratory infections, including influenza A and B, metapneumovirus, parainfluenza virus 1/2/3/4, adenovirus, rhinovirus A/B/C and respiratory syncytial virus A/B, to provide more insights for diagnosis of symptomatic patients especially with the emerging SARS-CoV-2 variants.
Primary screening for COVID-19, Flu and RSV
Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is designed to detect and differentiate between SARS-CoV-2, influenza A, influenza B and RSV
for primary screening during the upcoming flu season.
More reliable results using dual internal controls
- The endogenous and exogenous internal controls are designed to verify the entire process from sample collection to nucleic acid extraction and PCR steps
- The endogenous internal control enables validating correct sampling for self-collected specimens
Increased accuracy by minimizing risks
Multiplex real-time PCR with high sensitivity and specificity by utilization of Seegene’s proprietary technologies
Detecting N, S, RdRP and/or E target genes of SARS-CoV-2 to minimize the risk of genetic variations and allow high accuracy
No cross-reactivity confirmed with respiratory pathogens including SARS, MERS and SARS-related viruses
Powerful automation platform
Seegene’s automated molecular diagnostic platform allows a unique streamlined workflow with quick and simple steps for detection of COVID-19.
View video clips
Watch the videos that can show you the outstanding features and benefits of Seegene’s COVID-19 assays.
Kick your Real-time PCR up a notch!
With Seegene’s core technologies and proprietary know-hows, enhance your MDx products with incomparable performance and usability.
Oligo Design
Oligo design technology for high multiplex PCR: SG-Insilico™
Enables rapid designing of high multiplex oligos using Seegene-developed algorithms and confidential variables.
Amplification
Highly specific amplification technology for high multiplex PCR: DPO™
Allows the implementation of high multiplex diagnostics with unparalleled specificity using Seegene’s unique primer structure.
Target Detection
High multiplex target detection technology: TOCE™
Achieves accurate target signals by independently controlling multiple target signals for primer and probe annealing temperatures.
Quantitative
Detection
High multiplex target detection & quantification technology: MuDT™
Broadens capacity for high multiplex target detection & quantification by enabling analysis of multiple Ct values in a single detection channel.
Interpretation
High multiplex signal processing technology: DSP™
Enables accurate reporting of target’s positive or negative results through Seegene’s proprietary signal processing algorithms.